Delta 9 Cannabis Inc.
DLTNF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $71,065 | $63,228 | $62,291 | $52,047 |
| % Growth | 12.4% | 1.5% | 19.7% | – |
| Cost of Goods Sold | $56,621 | $52,350 | $44,972 | $34,049 |
| Gross Profit | $14,445 | $10,879 | $17,319 | $17,998 |
| % Margin | 20.3% | 17.2% | 27.8% | 34.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $15,438 | $19,207 | $8,494 | $9,347 |
| SG&A Expenses | $16,090 | $19,867 | $19,071 | $15,970 |
| Sales & Mktg Exp. | $652 | $660 | $10,576 | $6,623 |
| Other Operating Expenses | $11,848 | $11,270 | $5,888 | $4,796 |
| Operating Expenses | $27,938 | $31,137 | $24,959 | $20,766 |
| Operating Income | -$13,493 | -$20,258 | -$7,639 | -$2,079 |
| % Margin | -19% | -32% | -12.3% | -4% |
| Other Income/Exp. Net | -$3,142 | -$7,579 | -$3,904 | -$3,005 |
| Pre-Tax Income | -$16,636 | -$27,837 | -$11,543 | -$5,084 |
| Tax Expense | $0 | $0 | -$401 | $401 |
| Net Income | -$17,515 | -$28,113 | -$11,142 | -$5,485 |
| % Margin | -24.6% | -44.5% | -17.9% | -10.5% |
| EPS | -0.1 | -0.22 | -0.11 | -0.061 |
| % Growth | 54.5% | -100% | -79.4% | – |
| EPS Diluted | -0.098 | -0.22 | -0.11 | -0.061 |
| Weighted Avg Shares Out | 175,153 | 126,067 | 103,344 | 89,426 |
| Weighted Avg Shares Out Dil | 178,944 | 126,067 | 103,344 | 89,426 |
| Supplemental Information | – | – | – | – |
| Interest Income | $21 | $117 | $31 | $44 |
| Interest Expense | $6,806 | $6,507 | $3,899 | $3,198 |
| Depreciation & Amortization | $8,787 | $7,846 | $6,328 | $5,110 |
| EBITDA | -$1,042 | -$13,389 | -$1,316 | $3,224 |
| % Margin | -1.5% | -21.2% | -2.1% | 6.2% |